Aurinia Pharmaceuticals PEG Ratio

Aurinia Pharmaceuticals's peg ratio stands at 1458.26. That is above the Healthcare sector average of 12.15. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Aurinia Pharmaceuticals sits higher the Healthcare benchmark (12.15) with a PEG ratio of 1458.26. That is roughly 11899.3% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 1458.26 is attractive depends on Aurinia Pharmaceuticals's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Aurinia Pharmaceuticals's PEG ratio evolved across reporting periods, while the comparison chart places AUPH next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, PEG ratio is commonly used to spot outliers. Aurinia Pharmaceuticals's reading of 1458.26 (sector avg 12.15) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.